In vivo t-cell depletion with antithymocyte globulins improves overall survival after Myeloablative allogeneic stem cell transplantation in patients with hematologic disorders

Acta Haematologica

Volumn 129, Issue 3, 2013, Pages 146-153

  Sheng, Zhixin ^a,b   Ma, Huanwen ^b   Pang, Wenzheng ^c   Niu, Shanona ^d   Xu, Jingbo ^c  

^a SHANDONG UNIVERSITY   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

^c THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Allogeneic stem cell transplantation; Antithymocyte globulins; Graft versus host disease; Myeloablative transplantation; Overall survival; T cell depletion; Thymoglobulin

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; HAZARD RATIO; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; IN VIVO STUDY; LYMPHOBLASTIC LYMPHOMA WITH LEUKEMIA; LYMPHOBLASTOMA; META ANALYSIS; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); T CELL DEPLETION; TREATMENT RELATED MORTALITY; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; LYMPHOCYTE DEPLETION; MALE; METHODOLOGY; PROSPECTIVE STUDY; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL RATE; T LYMPHOCYTE; ACUTE DISEASE; APLASTIC ANEMIA; CHRONIC DISEASE; COCHRANE LIBRARY; EMBASE; LYMPHOMA; MEDLINE; MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION; PROGRESSION FREE SURVIVAL; RELAPSE; RETROSPECTIVE STUDY; SCISEARCH;

ANTILYMPHOCYTE SERUM; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; SURVIVAL RATE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 84870291977     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000343604     Document Type: Article

References (27)

1. Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP: Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14-21
2. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NK, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ: Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784-3792 (Pubitemid 350159650)
3. Martin PJ, Counts GW Jr, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, Flowers ME, Syrjala KL, Hansen JA, Storb RF, Storer BE: Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011-1016
4. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, Korthof E, Weis J, Levy V, Tichelli A: Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373-3385 (Pubitemid 36857917)
5. Lee SJ, Vogelsang G, Flowers ME: Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215-233 (Pubitemid 40045609)
6. Maraninchi D, Gluckman E, Blaise D, Guyotat D, Rio B, Pico JL, Leblond V, Michallet M, Dreyfus F, Ifrah N: Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet 1987; 2: 175-178 (Pubitemid 17091848)
7. Blaise D, Gravis G, Maraninchi D: Longterm follow-up of T-cell depletion for bone marrow transplantation. Lancet 1993; 341: 51-52 (Pubitemid 23007628)
8. Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M: Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 2011; 117: 6963-6970
9. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle- Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. http://www.ohri.ca/programs/clinical-epidemiology/ oxford.htm (accessed 2004)
10. Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-Analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834 (Pubitemid 28562978)
11. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR: Practical methods for incorporating summary time-to-event data into metaanalysis. Trials 2007; 8: 16
12. Egger M, Smith GD, Schneider M, Minder C: Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634 (Pubitemid 27387172)
13. Duval S, Tweedie R: A nonparametric 'trim and fill' method of accounting for publication bias in meta-Analysis. J Am Stat Assoc 2000; 95: 89-98
14. Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Barbanti M, Sacchi N, Van Lint MT, Bosi A: Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942-2947
15. Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Sacchi N, van Lint MT, Bosi A: Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560-565 (Pubitemid 43956361)
16. Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Socié G: Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009; 10: 855-864
17. Weiden PL, Doney K, Storb R, Thomas ED: Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts. Transplantation 1979; 27: 227-230 (Pubitemid 9157598)
18. Ramsay NK, Kersey JH, Robison LL, Mc- Glave PB, Woods WG, Krivit W, Kim TH, Goldman AI, Nesbit ME Jr: A randomized study of the prevention of acute graft-versushost disease. N Engl J Med 1982; 306: 392- 397 (Pubitemid 12168294)
19. Socié G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Finke J: Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-Tcell globulin ATG-Fresenius. Blood 2011; 117: 6375-6382
20. Mohty M, Boiron JM, Damaj G, Michallet AS, Bay JO, Faucher C, Perreau V, Bilger K, Coso D, Stoppa AM, Tabrizi R, Gastaut JA, Michallet M, Maraninchi D, Blaise D: Graftversus- myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 34: 77-84 (Pubitemid 39022961)
21. Russel JA, Turner AR, Larratt L, Chaudhry A, Morris D, Quinlan D, Stewart D: Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant 2007; 13: 299-306
22. Remberger M, Storer B, Ringdén O, Anasetti C: Association between pretransplant thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors. Bone Marrow Transplant 2002; 29: 391-397 (Pubitemid 34257712)
23. Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A, Huber C, Fauser AA, Schwerdtfeger R: Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant 2005; 35: 1011-1018 (Pubitemid 40711839)
24. Zander AR, Kröger N, Schleuning M, Finke J, Zabelina T, Beelen D, Schwerdtfeger R, Baurmann H, Bornhäuser M, Ehninger G, Fauser AA, Kiehl M, Trenschel R, Ottinger HD, Bertz H, Berger J, Kolb HJ, Schaefer UW: ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML). Bone Marrow Transplant 2003; 32: 355-361 (Pubitemid 37038844)
25. Bacigalupo A, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C, Dominietto A, Bruno B, Galbusera V, Frassoni F, Podesta M, Tedone E, Occhini D, Van Lint MT: Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants. Biol Blood Marrow Transplant 2002; 8: 656-661 (Pubitemid 36097804)
26. Bonifazi F, Bandini G, Stanzani M, Palandri F, Giannini B, Arpinati M, Rosti G, Baccarani M: In vivo T-cell depletion with lowdose ATG is effective in reducing cGvHD after peripheral blood stem cell myeloablative transplant in CML: results from a prospective phase II study. Bone Marrow Transplant 2005; 35: 1025-1026 (Pubitemid 40711842)
27. Ho VT, Soiffer RJ: The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 192-204.